摘要
目的探讨原发性肝癌(PHC)介入治疗并发症产生的原因和处理方法。方法回顾2002年4月至2004年4月268例PHC介入治疗的临床资料,分析肿瘤的TNM分期、Child-Pugh分级与并发症的关系。结果TNM分期Ⅲ-Ⅳ期病人介入后肝功能损害和栓塞后综合征发生率分别为67.6%和70.8%,明显高于Ⅱ期病人(P<0.05);Child-PughB-C级介入后栓塞后综合征为75.0%,明显高于对照组(P<0.05)。结论晚期肝癌伴肝功能不全病人较易产生介入治疗并发症,围介入期处理和个体化治疗是防止并发症的关键。
Objective： To investigate causes of complications in PHC reeiving transarterial interventlonal therapy and to find rational method of managements. Method： Clinic data of 268 eases receiving transarterial interventional therapy from April 2002 to April 2004 were studied retrospectively, relationships between TNM staging and Child - Pugh classification and complications were analyzed. Results： Incidence of complications of patients with PHC Ⅲ/Ⅳ stage and Child - Pugh classification B - C underwent interventional therapy was significant higher than control group （P 〈 0.05）. Conclusions： Advanced stage of PHC treated by interventional therapy with hepatic inadequacy is subject to complications. It would be critical for patients of PHC to be managed around intervention and with individualized treatment to prevent from eomplieatians.
出处
《华西医学》
CAS
2006年第2期298-299,共2页
West China Medical Journal
关键词
肝细胞肝癌
介入治疗
并发症
Primary hepatic carcinoma
Interventional therapy
Complication
